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Palate developmentBMP signaling plays many important roles during organ development, including palatogenesis. Loss of BMP
signaling leads to cleft palate formation. During development, BMP activities are ﬁnely tuned by a number of
modulators at the extracellular and intracellular levels. Among the extracellular BMP antagonists is Noggin,
which preferentialy binds to BMP2, BMP4 and BMP7, all of which are expressed in the developing palatal
shelves. Here we use targeted Noggin mutant mice as a model for gain of BMP signaling function to
investigate the role of BMP signaling in palate development. We ﬁnd prominent Noggin expression in the
palatal epithelium along the anterior–posterior axis during early palate development. Loss of Noggin function
leads to overactive BMP signaling, particularly in the palatal epithelium. This results in disregulation of cell
proliferation, excessive cell death, and changes in gene expression, leading to formation of complete palatal
cleft. The excessive cell death in the epithelium disrupts the palatal epithelium integrity, which in turn leads
to an abnormal palate-mandible fusion and prevents palatal shelf elevation. This phenotype is recapitulated
by ectopic expression of a constitutively active form of BMPR-IA but not BMPR-IB in the epithelium of the
developing palate; this suggests a role for BMPR-IA in mediating overactive BMP signaling in the absence of
Noggin. Together with the evidence that overexpression of Noggin in the palatal epithelium does not cause a
cleft palate defect, we conclude from our results that Noggin mediated modulation of BMP signaling is
essential for palatal epithelium integrity and for normal palate development.Regenerative Biology, Mount
ces, the Ohio State University,
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Cleft palate, one of the most frequent congenital birth defects in
the human, results from genetic or environmental perturbations in
palate development. Development of the mammalian secondary
palate is a multiple staged process, which begins in mice at embryonic
day 11.5 (E11.5), when the palatal shelves grow out of the bilateral
maxillary processes. The palatal shelves continue to grow vertically
along the developing tongue until E14.0, and then bend abruptly to a
horizontal position above the tongue. At E14.5, the growing palatal
shelves meet each other and fuse in the midline, separating the oral
cavity from the nasal cavity. Each step of palate development, like the
formation of many other mammalian organs, is directed by reciprocaland sequential epithelial–mesenchymal interactions (Ferguson and
Honig, 1984; Ferguson, 1988; Hall, 1992).
The palatal shelves are composed of the epithelial covering and the
mesenchymal tissue that is derived largely from cranial neural crest
cells, and also from cranial paraxial mesoderm (Ferguson, 1988; Ito et
al., 2003). The palatal epithelium, consisting of a basal columnar cell
layer and covering periderm cells, is a heterogeneous structure. Based
on the cell morphology, position, and genetic markers, the palatal
epithelium can be divided into nasal, oral, andmedial edge epithelium
(MEE) (Ferguson, 1988). Prior to palatal elevation, the nasal portion of
the palatal epithelium differentiates into pseudostratiﬁed nasal
epithelial cells, and the oral portion differentiates into squamous
oral epithelial cells. The MEE, which is positioned between the oral
and nasal regions, develops into a single layered epithelial seam upon
the contact and fusion of two palatal shelves, and ultimately
diminishes to form an intact palatal shelf. During palate development,
the integrity of palatal epithelium is essential for palate elevation.
Disruption of this integrity would usually lead to abnormal adhesion
or fusion between the elevating palatal shelves with adjacent
structures, such as tongue and mandible, resulting in delayed or
failed palate elevation, and consequently, generating a cleft palate
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Xiong et al., 2009).
The Bone Morphogenetic Proteins (BMPs) have been implicated in
mammalian palate development (Nie et al., 2006). Several Bmp genes,
including Bmp2, Bmp4 and Bmp7, are expressed in the developing
mouse palatal shelves (Lu et al., 2000; Zhang et al., 2002; Nie, 2005;
Levi et al., 2006). The requirement for BMP signaling in palate
development was initially demonstrated inMsx1mutant mice, which
exhibit the cleft palate phenotype (Zhang et al., 2002). In the Msx1
mutant palate, Bmp4 expression is abrogated and ectopic expression
of its human ortholog rescues the cleft palate phenotype in Msx1
mutant. Furthermore, tissue-speciﬁc inactivation of the genes encod-
ing type I BMP I receptors, such as Bmpr-IA (Alk3) and ActRIa (Alk2), or
overexpression of the BMP antagonist Noggin in the palatal
mesenchyme leads to cleft palate formation in corresponding mouse
models (Dudas et al., 2004; Liu et al., 2005; Xiong et al., 2009). These
lines of evidence indicate an essential role for BMP signaling in palate
development. On the other hand, inactivation of the promiscuous
TGFβ antagonist Follistatin causes a cleft palate phenotype, raising the
possibility that an elevated level of BMP signaling also impairs palate
development (Matzuk et al., 1995).
During embryonic development, BMP signaling is ﬁnely tuned by a
number of modulators at different levels (Gazzerro and Canalis,
2006). The intracellular modulators, such as Smad6, Smurf and Tob,
can prevent R-Smads activation by interrupting their binding to
receptors and Smad4, or mediate R-Smad degradation. At the
extracellular level, BMP antagonists modulate BMP signaling activity
by blocking selective ligands from binding to their receptors. A
number of such extracellular antagonists have been documented,
including Noggin, Chordin, Follistatin, and other molecules (Balemans
and Van Hul, 2002; Gazzerro and Canalis, 2006). Among them, Noggin
is a secretory polypeptide that binds preferentially to BMP2, BMP4,
and BMP7 to prevent their signaling (Zimmerman et al., 1996; Groppe
et al., 2002; Chen et al., 2004). Noggin (Nog) deﬁcient mice exhibit a
series of defects in organogenesis (Brunet et al., 1998; McMahon et al.,
1998; Bachiller et al., 2000), including a spectrum of craniofacial
defects, accompanied with upregulation of BMP activities (Bachiller et
al., 2000; Stottmann et al., 2001; Anderson et al., 2006). However, a
cleft palate defect in Nog−/− mice has not been reported.
We have previously investigated the role of BMP signaling in
palate development using loss-of-functionmodels (Zhang et al., 2002;
Xiong et al., 2009). In this study, we used a conventionally gene-
targeted Noggin mutant line (Nog−/−) (McMahon et al., 1998) as a
gain-of-BMP function model to further evaluate the role of BMP
signaling in palate development. We report here that Nog−/− mice
exhibit a cleft palate defect. BMP/Smad signaling is ectopically
activated in the Nog−/− palatal epithelium, consistent with the
restricted Noggin expression pattern in the developing palate. Our
results show that palatal epithelium integrity is disrupted in the Nog
−/− palate and this disruption leads to an abnormal palate-mandible
fusion, preventing the normal palate elevation. This phenotype is
recapitulated in a transgenic model in which BMP receptor-IA
mediated signaling is ectopically activated in the developing palate.
In contrast, overexpression of Noggin in the palatal epithelium does
not cause a cleft palate defect. We therefore conclude that Noggin-
mediated repression of BMP signaling in the palatal epithelium is
required for normal palate development.
Materials and methods
Animals
The generation and genotyping of Nog+/−, K14Cre and pMesNog
mice have been described previously (McMahon et al., 1998; Andl et
al., 2004; Xiong et al., 2009). In Nogmutant mice, a null Nog allele was
created by fusing the ﬁrst 10 amino acids of the Noggin codingsequence to the lacZ gene so that the LacZ expression is under the
control of the Nog regulatory elements (McMahon et al., 1998). The
pMescaBmpr-IA and pMescaBmpr-IB transgenic mice were generated
in a strategy similar to pMesNog mice (Xiong et al., 2009). Brieﬂy, a
constitutively active form of the chick Bmpr-IA (caBmpr-IA) with Gln-
233 to Asp replacement and a constitutively active form of Bmpr-IB
(caBmpr-IB) with Gln-203 to Asp change (Zou et al., 1997) were
cloned into pMes-IRES-Egfp vector at the 5' end of the IRES-Egfp
sequence, and the 3’ end of the LoxP ﬂanked STOP cassette, which is
under the control of the chick β-actin promoter. Pronuclear injection
was performed to generate transgenic founders. Transgene expres-
sion in each potential transgenic line was identiﬁed by Egfp
expression and further conﬁrmed by in situ hybridization. Embryos
were collected from time-mated pregnant mice and dissected in ice-
cold PBS treated with diethyl pyrocarbonate (DEPC). Embryonic head
samples were then separated from the trunk, ﬁxed in 4% paraformal-
dehyde (PFA) overnight at 4 °C, and processed for parafﬁn section or
frozen section for immunostaining. A tail sample from each embryo
was used for PCR-based genotyping (primer information available
upon request). Nog+/− mice were maintained in a C57/B6 back-
ground. The pMesNog, pMescaIA, and pMesBmpr-IB transgenic mice
were maintained in an outbred CD1 background. All animals and
procedures used in this study were approved by the Tulane University
Institutional Animal Care and Use Committee.
In vitro organ culture
Paired secondary palatal shelves from individual E13.5 embryos
were isolated; the anterior halves of the palatal shelves were
dissected and collected. Paired anterior palatal shelves were placed
in Trowell type organ culture, and were orientated so that the MEE of
each palatal shelf was in contact, as described previously (Taya et al.,
1999; Zhang et al., 2002). Samples were cultured in DMEM media
supplemented with 20 % FCS at 37 °C in an incubator ﬁlled with 5%
CO2 for 3 days, and were then harvested for histological examination.
Histology, in situ hybridization, immunostaining, and X-gal staining
After ﬁxation, staged embryonic head samples were dehydrated
through gradient ethanol series, cleared in xylene, and embedded in
parafﬁn. Coronal sections at 10 μm were collected for either Hematox-
ylin/Eosin staining or non-radioactive in situ hybridization, as described
previously (St. Amand et al., 2000). Three independent experiments
were carried out for gene expression by in situ hybridization.
Immunostaining was performed as described previously (Xiong et al.,
2009). Phospho-Smad1 (Ser463/465)/Smad5 (Ser463/465)/Smad8
(Ser426/428) antibody from Cell Signaling (catalog #9511) was used
to detect Smad dependent BMP signaling activities. For X-gal staining,
Nog+/− embryos were collected frommating of Nog+/−mice with wild
type mice at designated time points, and the tail of each embryo was
used for genotyping. Embryonic heads were removed, labeled, and
individually ﬁxed in 0.2% glutaraldehyde for overnight at 4 °C. After
genotyping, Nog+/− embryonic heads were washed in ice cold PBS,
washed in 30% sucrose/PBS solution overnight, and embedded in O.C.T
(Tissue-Tek). Cryosections at 10 μmwere processed for X-gal staining, as
described previously (Ito et al., 2003). For whole mount X-gal staining,
samples were ﬁxed for 20 min in 0.2% glutaraldehyde, and subjected to
staining according to the standard protocol (Chai et al., 2000).
Cell proliferation and TUNEL assays
Bromodeoxyuridine (BrdU) Labeling and Detection Kit (Roche
Diagnostics Corporation, Indianapolis) was used to measure cell
proliferation rate. Brieﬂy, BrdU solutionwas injected intraperitoneally
into timed pregnant female mice (1.5 ml/100 g body weight) 1 h
before embryos were harvested. Embryonic heads were ﬁxed in
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immunostaining according to manufacturer's instruction. For BrdU-
labeled cell counting, an arbitrary area was deﬁned and both BrdU
labeled cells and total cells were counted in that area. The outcome of
BrdU labeling was presented as percentage of labeled cells among
total nuclei in the ﬁxed region. Collected from nine continuous
sections of three individual samples of wild type controls and
mutants, respectively, data were subjected to Student's t-test to
determine the signiﬁcance of differences. For TUNEL assays, samples
were processed into 5 μm parafﬁn sections and apoptotic cells were
detected as described previously (Alappat et al., 2005).
Results
The role of BMP signaling in palate development has been
previously studied using various loss-of-function models (Zhang et
al., 2002; Liu et al., 2005; Xiong et al., 2009). The cleft palate defects in
mice deﬁcient for Follistatin further suggest a requirement for a ﬁnely
tuned level of TGFβ ligand activity in normal palate development
(Matzuk et al., 1995), including that of BMPs. Noggin is a speciﬁc
extracellular antagonist of BMP signaling that modulates BMP
activities during embryonic development. Noggin-deﬁcient mice
therefore provide a gain-of-function model to study the role of BMP
signaling in organ development. Besides defects found in many other
developing organs, Nog−/− mice also exhibit a spectrum of cranio-
facial defects, suggesting a role for Noggin in palate development
(McMahon et al., 1998; Bachiller et al., 2000; Stottmann et al., 2001;
Anderson et al., 2006). However, neither expression nor function of
Noggin has been documented in mammalian palate development.
Expression of Noggin in the developing palate
To investigate the potential role of Noggin and BMP signaling in
palatogenesis, we began with an examination of Noggin expression by
in situ hybridization. We found a dynamic Noggin expression pattern,
primarily encompassing the palatal epithelium (Fig. 1). At E11.5,
Noggin is expressed in the entire palatal epithelium along the
anterior–posterior (A–P) axis (Fig. 1A, B). At E12.5, in the anterior
portion of the palatal shelves, Noggin expression remains in the
epithelium, but is relatively weak in the nasal side and the MEE
(Fig. 1C), while in the posterior portion, Noggin expression was only
detected in the oral side palatal epithelium (Fig. 1D). At E13.5, Noggin
expression is restricted to the oral side epithelium in both the anterior
and posterior palate (Fig. 1E, F). In the craniofacial region, Noggin
mRNAs were also detected in the oral epithelium, maxillary
mesenchyme, tongue and Meckel's cartilage (Fig. 1). We further
assayed the Noggin expression pattern by X-gal staining in Nog+/−
embryos, which carry a LacZ knock-in maker (Fig. 1G, H; and
Supplemental Fig. 1A–D; McMahon et al., 1998); these results
conﬁrmed the expression pattern detected by in situ hybridization.
The spatiotemporal proﬁle of Noggin expression suggests an involve-
ment of Noggin in palate development, prompting us to examine
potential palate phenotypes in Nog−/− mice.
Nog−/− mice exhibit complete cleft palate phenotype
Gross examination of Nog−/− mice at postnatal day 0 (P0)
identiﬁed a complete clefting of the secondary palate with 100%
penetrance (Fig. 1J). Histological analyses revealed that the Nog−/−
palatal shelves exhibit morphology comparable to the wild type
control until E12.5, when the anterior palatal shelves looked normal
but posterior palatal shelves appeared slightly smaller than their wild
type counterparts (data not shown). At E13.5, the anterior portion of
the palatal shelves in the mutants appeared smaller than in the wild
type controls, and the posterior palate also appeared slightly shorter
(Fig. 2A–D). During normal embryogenesis, the palatal shelves elevateand fuse at the midline at E14.5 (Fig. 2E, G). In Nog−/− embryos, we
observed that the anterior palatal shelves elevated to horizontal
position above the tongue, but did not meet medially. In contrast, the
posterior portion of the palatal shelves fused with the mandible and
did not elevate at all (Fig. 2F, H). In addition to the defect in palate
development, signiﬁcantly enlarged Meckel's cartilage was also
observed in Nog−/− embryos (Fig. 2), consistent with Noggin
expression in Meckel's cartilage and its general role in skeletal
development (Brunet et al., 1998; McMahon et al., 1998).
The failed palatal shelf contact at themidline in the anterior region of
Nog−/− palate could be caused by an impaired palatal fusion. To test this
possibility,weused invitroorganculture asdescribedpreviously (Taya et
al., 1999; Zhang et al., 2002). The anterior halves of the palatal shelves
from E13.5 wild type controls and Nog−/− embryos were dissected and
placed in contact as pairs with the MEE of each facing the other. After
3 days in culture, paired palatal shelves from both genotypes underwent
fusion (5/5 forwild type control, and 6/6 forNogginmutant), as revealed
by the disappearance of the midline seam (Supplemental Fig. 2),
indicating that failure of fusion is not the cause of cleft palate in Nog−/
− embryo. Many factors are known to inﬂuence palatal shelf contact,
including malformed craniofacial structures. Since micrognathia was
rarely found in Nog−/−mutants (Stottmann et al., 2001), the cleft palate
is not secondary to micrognathia where the tongue fails to sink down
frombetween thepalatal shelves.However, the lackof theprimarypalate
(see below) and the formation of enlarged Meckel's cartilage could also
attribute to the failure in palatal shelf contact. Nevertheless, these
observations revealed a requirement for Noggin in palate development.
In addition to the cleft secondary palate formation, the primary
palate was also absent completely in Noggin mutants (Fig. 1J),
consistent with Noggin expression in the forming site of primary
palate and surrounding tissue (Stottmann et al., 2001; Supplemental
Fig. 1E, F). However, we did not observe any type of cleft lip formation,
although we indeed found defective maxillary incisors that were
fused at the midline to form a single tooth bud which was arrested at
the late bud stage (unpublished results).Alteration of BMP signaling in the Nog mutant palate
Noggin functions to antagonize the activities of selective speciﬁc
BMP ligands, such as BMP2, BMP4, and BMP7, which signal primarily
by phosphorylating Smad1/5/8 and activating the Smad4 dependent
pathway. Although Smad-independent TGFβ/BMP signaling through
p38 MAPK has also been implicated in palate development, this
pathway mainly acts in the MEE region to regulate palatal fusion (Xu
et al., 2008). We therefore used Smad1/5/8 phosphorylation as an
indicator of BMP activated Smad signaling to determine changes in
the level of BMP signaling in the Nog−/− palatal shelves. In the wild
type palatal shelves, phosphorylated Smad1/5/8 (pSmad1/5/8) was
detected in both anterior and posterior portion (Fig. 3A, E). In the
anterior palate, we found abundant pSmad1/5/8 staining in the
maxillary and palatal mesenchyme, with a few positive signals in the
epithelium (Fig. 3A, C). In the posterior palate, pSmad1/5/8 was
restricted to the nasal side palatal mesenchyme, with sporadic
staining in the oral side palatal mesenchyme and epithelium, and
completely negative staining in the Meckel's cartilage (Fig. 3E, G). In
Nog−/− embryos, Smad1/5/8 phosphorylation was dramatically
elevated in the maxillary mesenchyme and the Meckel's cartilage
(Fig. 3B, F). However, in the mutant palate, we detected differential
alterations in pSmad1/5/8 staining. In the anterior palatal mesen-
chyme, the staining was generally reduced (Fig. 3B, D). In contrast, in
the posterior palatal mesenchyme, ectopic staining was found in the
oral side region, while the nasal half remained comparable staining to
the wild type controls (Fig. 3F, H). In the mutant palatal epithelium,
we found consistently ectopic pSmad1/5/8 staining in the oral side
epithelium along the A–P axis (Fig. 3), in accord with the Noggin
Fig. 1. Expression of Noggin in the developingmouse palatal shelves. (A, B) At E11.5,NogginmRNA is detected in the epithelium of the oral-nasal cavity, including the anterior (A) and
posterior (B) palatal shelves. (C, D) In the anterior palatal shelves at E12.5, Noggin expression is detected in the nasal side and oral side palatal epithelium, but not in the MEE (C),
while in the posterior palate, Noggin mRNA is restricted to the oral side palatal epithelium (D). (E–H) At E13.5, Noggin expression (arrows) is only detected in the oral side palatal
epithelium (arrows) in both the anterior (E) and posterior (F) palatal shelves. LacZ reporter expression in the Nog+/− palate recapitulates the expression pattern of Noggin mRNA
(G, H). (I, J) At P0, the wild type mouse develops an intact palatal shelf (I), while Nog−/− mouse exhibits a complete cleft of the secondary palate (asterisks in J) and a lack of the
primary palate (arrow in J). M, Meckel's cartilage; MEE, medial edge epithelium; PP, primary palate; PS, palatal shelf; T, tongue. N designates nasal side of the palatal shelf, and O
designates oral side of the palatal shelf. Scale bars represent 100 μm.
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epithelium indicates that Noggin is required to inhibit Smad
dependent signaling in normal palate development. The different
alterations in pSmad1/5/8 staining in the mutant palatal mesen-chyme, on the other hand, suggest that palatal mesenchyme along the
A–P axis responds differentially to the absence of Noggin, consistent
with the tissue heterogeneity along the A–P axis of the developing
palatal shelves (Hilliard et al., 2005; Okano et al., 2006).
Fig. 2. Nog−/− embryos show defective palate development. (A, C) At E13.5, the wild type palatal shelves grow vertically along the tongue in the oral-nasal cavity. (B, D) In E13.5
mutant, the anterior palatal shelves appear smaller than the wild type controls (B); in the posterior portion, the mutant palatal shelves grow shorter but slightly wider than the wild
type counterparts, accompanied by ectopic cartilage formation and hyperplastic Meckel's cartilage (D). (E, G) At E14.5, the palatal shelves in wild type embryos have elevated and
fused to form an intact structure above the tongue. (F, H) In the mutant at E14.5, however, the palatal shelves fail to contact each other, forming a palatal cleft (asterisk). Note that in
the mutant, the anterior palatal shelves have elevated but did not make contact (F), while the posterior palatal shelves remain in a vertical position, and show abnormal fusion
(arrow) with the mandible (H). M, Meckel's cartilage; MNP, medial nasal process; PS, palatal shelf; T, tongue. Scale bars represent 200 μm.
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It has been well documented that Bmp2 and Bmp4 are expressed in the
developing palate, and it has been shown that exogenous BMP can
induce its antagonists expression, and vice versa (Lu et al., 2000;
Stottmann et al., 2001; Ashique et al., 2002; Zhang et al., 2002; Nie,
2005). These lines of evidence promoted us to examine if inactivation of
Noggin could also affect Bmp2 and Bmp4 expression in the developing
palate. We found that the expression of Bmp4 is comparable to that in
thewild type control (Fig. 4A, B). This observation is consistentwith the
unaltered expression patterns of Msx1 and Shh, downstream targets of
Bmp4 in the anterior palate (Fig. 4C–F). In the wild type controls at
E13.5, Bmp2 is expressed in the palatal mesenchyme of the anterior
portion, and in theMEE as well as the nasal side palatal mesenchyme of
the posterior portion (Fig. 4G, I). In the Nog−/− palate, we found that
Bmp2 expression is reduced in the anterior palatal mesenchyme, but isectopically activated in the oral side of posterior palatal epithelium
(Fig. 4H, J), suggesting that Noggin regulates Bmp2 expression through
different mechanisms along the A–P axis in the developing palate. In
contrast, Bmp2 expression in the anterior maxillary mesenchyme
and the posterior palate mesenchyme of the mutant was not affected
(Fig. 4G–J). The down-regulation of Bmp2 expression in the anterior
palatal mesenchyme is accompanied by a reduced expression of Shox2
(Fig. 4K, L), whose expression is restricted in the anterior palatal
mesenchyme and is dependent on BMP activities (Yu et al., 2005).
These results indicate that, in addition to its antagonizing property,
Noggin is also able to regulate the expression of Bmp2, but not Bmp4, in
the developing palate. The alteration in Bmp2 expression could at least
partially account for the changes in pSmad1/5/8 activity in themutant
palate along the A–P axis, and a down-regulation of Shox2 expression
in the anterior palatal mesenchyme.
Fig. 3. Noggin deﬁciency alters BMP/Smad signaling activity in the developing palate. (A, C, E, G) In the wild type control at E13.5, pSmad1/5/8 is detected in both the anterior and
posterior palate. In the anterior palate, pSmad1/5/8 signal is found at high levels in the mesenchyme but is sparse in the epithelium (A, C); in the posterior palate, pSmad1/5/8/
activity is mainly restricted in the nasal side palatal mesenchyme, with a few positive signals in the oral side palatal epithelium (E, G). (B, D, F, H) In the Nog−/− palate at the
comparable stage, Smad1/5/8 phosphorylation is enhanced in the oral side palatal epithelium, in both the anterior and posterior palate. As compared to the wild type control, the
mutant anterior palatal mesenchyme exhibits downregulated pSmad1/5/8 signal, while the posterior palatal mesenchyme shows ectopic pSmad1/5/8 activity in the oral side. Note
that the pSmad1/5/8 signal is signiﬁcantly enhanced in the Nog−/−Meckel's cartilage (F). The straight white line in (E) and (F) divides the palatal mesenchyme into nasal and oral
halves. The dash white lines in (C, D, G, H) demarcate the epithelial boundary. M, Meckel's cartilage; T, tongue. N designates nasal side of the palatal shelf, and O designates oral side
of the palatal shelf. Scale bars represent 100 μm.
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To reveal the underlying cellular mechanisms that lead to a cleft
palate formation in the Nog −/− palate, we carried out BrdU labeling
and TUNEL assays to examine cell proliferation rates and apoptosisFig. 4. Gene expression in the wild type and Nog−/− palate. (A, B) At E13.5, Bmp4 is express
(A); in the Nog−/− palate, comparable Bmp4 expression (arrow) is observed (B). (C, D) Com
type (C) and Nog−/− embryo (D). (E, F) Shh expression (arrows) in the MEE of the anterior p
expression is detected in the anterior palatal mesenchyme and maxillary region (open arrow
the MEE region (I). (H) In the Nog−/− anterior palate, Bmp2 expression is downregulated in
arrow). (J) In the posterior palate of themutant, Bmp2 expression is not altered in the palatal
(arrows). (K, L) Shox2 expression is signiﬁcantly down-regulated in the anterior palatal mes
Shox2 expression at the ventral–lateral side of the developing tongue (red arrows). PS, palalevels, respectively. In this study, cell proliferation rate was measured
by the ratio of proliferating cells against total nucleus number in a
deﬁned area. At E12.5, while slight deviation in cell proliferation rates
was found in the both palatal epithelium and mesenchyme along the
A–P axis in the wild type controls and mutants (data not shown), theed in the anterior palatal mesenchyme (arrow) underlying MEE in the wild type palate
parable Msx1 expression is observed in the anterior palatal mesenchyme of E13.5 wild
alatal shelves is not affected in Nog−/− embryo. (G, I) In E13.5 wild type controls, Bmp2
) (G); in the posterior palate, it is expressed in the nasal side palatal mesenchyme and
the palatal mesenchyme (black arrow), but is not affected in the maxillary region (open
mesenchyme and theMEE, but is ectopically activated in the oral side palatal epithelium
enchyme of the mutant (L), as compared to the wild type control (K). Note comparable
tal shelf; T, tongue. Scale bars represent 100 μm.
115F. He et al. / Developmental Biology 347 (2010) 109–121
Fig. 5. TheNog−/− palatal shelves exhibit defective cell proliferation and excessive apoptosis. (A–D) Coronal sections of BrdU labeled palatal shelf in the wild type and Nog−/− palate
at E13.5. The blue bracket deﬁnes the regions used for cell proliferation ratio statistics. (E) Statistical data analysis shows cell proliferation rate is upregulated in the mutant palatal
epithelium (both anterior and posterior). Cell proliferation rate is downregulated in the mutant anterior palatal mesenchyme, but remains unaltered in the posterior palatal
mesenchyme. (F, G) At E13.5, the anterior palate of mutant exhibits excessive apoptotic cells in the oral side epithelium, but not in the nasal side (G), as compared to the wild type
control (F). Ant. Epi., epithelium of anterior palate; Ant. Mes., mesenchyme of anterior palate; Pos. Epi., epithelium of posterior palate; Pos. Mes., mesenchyme of posterior palate;
*Pb0.01. Scale bars represent 100 μm.
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results. However, at E13.5 in the mutants, we found that the cell
proliferation rate was signiﬁcantly upregulated in the oral side palatal
epithelium, in both the anterior and posterior portion, as compared to
the wild type controls (Fig. 5A–E). This elevated cell proliferation
rate appears to correlate with an enhanced pSmad1/5/8 staining in
the Nog−/− palate, suggesting that BMP/Smad signaling positively
modulated cell proliferation levels in the palatal epithelium. However,in the mutant mesenchyme, the cell proliferation rate was down-
regulated in the anterior region, but remained unchanged in the
posterior portion despite ectopic pSmad1/5/8 staining in the oral half,
as compared to the wild type controls (Fig. 5A–E). This observation is
consistent with our previous ﬁndings that exogenous BMP induces
cell proliferation in the anterior palatal mesenchyme but not in the
posterior palatal mesenchyme (Hilliard et al., 2005), and that a
reduced level of cell proliferation is observed in the anterior palatal
117F. He et al. / Developmental Biology 347 (2010) 109–121mesenchyme of Shox2 mutant (Yu et al., 2005). We next carried out
TUNEL assay to examine cell apoptosis in the wild type and Nog−/−
palate at E13.5. We detected no apoptotic cell in the wild type control
(Fig. 5F), but in the mutant, on the other hand, we found numerous
apoptotic cells in the anterior palatal epithelium on the oral side,
where Noggin is normally expressed (Fig. 5G). Ectopic apoptotic cells
were not found in the nasal side epithelium. However, in the posterior
palate of the mutant, we did not ﬁnd apoptotic cells at this particular
stage (data not shown). Thus alterations in cell proliferation rate and
enhanced cell apoptosis contribute to abnormal growth and shaping
in the mutant palatal shelves.
Nog−/− mice exhibit abnormal fusion between the posterior palate and
the mandible
Palate elevation defects could arise from multiple etiologies, such
as intrinsic elevation force deﬁciency, extrinsic blockage by the
tongue, or abnormal fusion between palate shelf and adjacent
structures (Gritli-Linde, 2007). As shown in Fig. 2, while the anterior
portion of the mutant palate elevated normally, the posterior palate
failed to elevate, apparently due to an aberrant palate-mandible
fusion. To reveal the process of the abnormal fusion, we examined
serial histological sections of the Nog−/− palatal shelves at E14.5
when they would have elevated to the horizontal position above theFig. 6. Nog−/− embryo shows abnormal palate-mandible fusion in the posterior palatal regi
tongue and merged at the midline. (B, C, E, F) In the Nog−/− embryo at the comparable stage
fusion (F) with the mandible. The asterisks denote a conﬂuence of mesenchyme. The pre
(G, H) Tgfβ3 is expressed in the MEE of the wild type palatal shelves (G); in the Nog−/− pa
activated in the oral side epithelium (red arrows in H) where aberrant palate-mandible adhes
side palatal epithelium prior to abnormal palate-mandible adhesion. No apoptotic cells are ob
autoﬂuorescence from blood cells. The yellow line marks the basement membrane betwee
PS, palatal shelf. Scale bars represent 100 μm.tongue (Fig. 6A). We observed an initial adhesion of the palatal
epithelium with the mandibular epithelium, followed by an elimina-
tion of the adhered epithelia, forming a mesenchymal continuity
between the palatal shelf and the mandible. Similar abnormal palate-
mandible fusion phenotype has been reported in Fgf10−/−mice (Rice
et al., 2004; Alappat et al., 2005). In Fgf10 mutants, cell apoptosis
induced by ectopic Tgfβ3 expression was thought to attribute to the
disruption of palatal epithelial integrity and abnormal fusion (Alappat
et al., 2005). The phenotypic similarity betweenNog−/− and Fgf10−/−
mice promoted us to examine if the expression of Fgf10 and its
downstream effectors was altered in the Nog−/− palate. We did not
see a down-regulation of Fgf10 expression in the Nog−/− palate (data
not shown). However, we indeed observed an ectopic Tgfβ3
expression in the oral side epithelium of the mutant posterior palatal
shelves prior to adhesion (Fig. 6H), although Tgfβ3 expression in the
mutantMEE remained comparable to that in wild type controls where
palatal shelves just met at the midline (Fig. 6G, H). Associated with
this ectopic activation of Tgfβ3 expression is aberrant induction of
apoptosis in the periderm cells prior to adhesion (Fig. 6I). Together
with our pSmad1/5/8 immunostaining results, these results suggest
that Noggin functions downstream of or in parallel to Fgf10 in
inhibiting Tgfβ3 expression in the oral side palatal epithelium, and an
elevated BMP/Smad signaling in the posterior palate can activate
Tgfβ3 expression and induce epithelial cell apoptosis, whichon. (A, D) At E14.5, the wild type palatal shelves have elevated to a position above the
, the palatal shelves remain in a vertical position, showing progressive adhesion (E) and
sence of the maxillary molar (arrows in A, B and C) marks the level of the sections.
late, Tgfβ3 expression is not affected in the MEE (black arrow in H), but is ectopically
ion occurs. (I) TUNEL assay detects ectopic apoptotic periderm cells (arrows) in the oral
served in the adjacent mandible epithelium. The yellow ﬂuorescent dots in (I) represent
n palatal mesenchyme and the basal epithelial layer. M, Meckel's cartilage; T, tongue;
118 F. He et al. / Developmental Biology 347 (2010) 109–121consequently disrupts palatal epithelium integrity and leads to
abnormal palate-mandible fusion.
Ectopic activation of BMP signaling in the palate epithelium
recapitulates the abnormal palate-mandible fusion phenotype in
Nog−/− mice
To test if ectopic activation of BMP signaling in the developing
palatal epithelium could recapitulate the abnormal palate-mandible
fusion phenotype observed in Nog−/−mice, we generated conditional
transgenic mice that express a constitutively active form of BMP
receptor-IA (pMescaBmpr-IA) or a constitutively active form of BMP
receptor-IB (pMescaBmpr-IB) upon crossing to a Cremouse line. These
mutated forms of BMP receptors have been demonstrated to activate
BMP signaling pathway in the absence of BMP ligands (Zou et al.,
1997; Zhang et al., 2000). Using a K14-Cre mouse line (Andl et al.,
2004; Xu et al., 2008), we ectopically expressed caBmpr-IA or caBmpr-
IB in embryonic epithelium, conﬁrmed by assessing expression of an
Egfp transgene integrated into the transgenic vector (Fig. 7C). As
shown in Fig. 7B, this K14-Cre transgenic allele was able to activate
Rosa26 reporter expression uniformly in craniofacial region as early as
E11.5, including the developing palatal shelves. We found that miceFig. 7. Ectopic activation of BMP signaling in the palatal epithelium recapitulates the palate-m
head shows negative staining of β-galactosidase. (B) An E11.5 K14Cre;R26R embryonic head s
(C) An E17.5 K14Cre;pMescaBmpr-IA embryo shows GFP expression throughout the entire em
fusion and failure in palatal shelf elevation in the posterior portion. (E) An E16.5 K14Cre;pM
area in (D), showing an abnormal palate-mandible adhesion/fusion sites (arrows). T, tongucarrying the K14-Cre and caBmpr-IB double transgenic alleles (K14Cre;
caBmpr-IB) did not develop a cleft palate defect (data not shown).
However, these mice in fact developed severe ichthyosis-like skin
phenotype postnatally, indicating a functional transgenic allele (Yu, X.
et al., unpublished results). The K14Cre;pMescaBmpr-IA mice, howev-
er, exhibited a cleft palate phenotype (data not shown). Histological
analyses revealed an abnormal palate-mandible fusion in the
posterior palate region at E14.5, resembling the phenotype found in
Nog−/− mice (Fig. 7D, F). We have shown previously that transgenic
overexpression of Noggin in the palatal mesenchyme causes a cleft
palate defect (Xiong et al., 2009). Using the same conditional Noggin
transgenic line (pMesNog), we overexpressed Noggin in the palatal
epithelium by compounding the K14-Cre allele with the pMesNog
conditional transgenic allele (Supplemental Fig. 1G). While mice
carrying the K14Cre and pMesNog transgenic alleles exhibited an
arrest of tooth development at the lamina/early bud stage (data not
shown), they did not develop a cleft palate defect (Fig. 7E), consistent
with the previous report that mice carrying the K14-Noggin transgenic
allele survived to adulthood (Plikus et al., 2005). These results support
the idea that repression of BMP activities by Noggin in the palatal
epithelium is required for the maintenance of palatal epithelium
integrity and is essential for normal palatogenesis.andible fusion phenotype observed in Nog−/−mice (A) An E11.5 wild type embryonic
hows staining of β-galactosidase in the craniofacial region, including the palatal shelves.
bryo. (D) An E14.5 K14Cre;pMescaBmpr-IA embryo exhibits abnormal palate-mandible
esNog embryo shows a normally formed palate. (F) Higher magniﬁcation of the deﬁned
e; PS, palatal shelf. Scale bars represent 100 μm.
119F. He et al. / Developmental Biology 347 (2010) 109–121Discussion
In this paper, we report the expression pattern of the BMP
antagonist Noggin in the mouse developing palate, and show that
inactivation ofNoggin causes a cleft palate formation.We demonstrate
that both cell proliferation and cell apoptosis are deregulated in the
Nog−/− palate. Particularly, we found abnormal cell apoptosis in
periderm cells in the oral side of the posterior palate, which leads to
aberrant palate-mandible fusion and blocks the normal palatal
elevation. We further show that ectopic activation of BMP signaling
in the palatal epithelium recapitulates the abnormal palate-mandible
fusion phenotype observed in Nog−/− mice. Our studies thus
demonstrate that repression of BMP activities by Noggin is required
for palate epithelium integrity, which is essential for normal palate
development.
Palatal epithelium integrity and palate development
Epithelial–mesenchymal interaction controls each step of palate
development. Palatal epithelium thus plays an essential role in palate
shelf outgrowth, elevation, fusion and further differentiation (Fergu-
guson, 1988). In addition to these aspects, recent studies have
demonstrated that the integrity of palatal epithelium is particularly
required for palate elevation (Alappat et al., 2005; Casey et al., 2006;
Jiang et al., 1998; Richardson et al., 2006, 2009; Xiong et al., 2009). In
normal palate development, the palatal shelves may contact the
adjacent tissues, including tongue and mandible. However, a clear
epithelial boundary is always maintained at the contact interface,
preventing abnormal adhesion and fusion between palate and these
structures. In pathological conditions, when the epithelium integrity
is disrupted, abnormal adhesion or fusion occurs. Abnormal adhesion
is observed in Irf6 heterozygous mice: the palatal epithelium adheres
to the mandible and the tongue; however, the palatal shelves still
manage to elevate and fuse to form an intact structure despite the
abnormal epithelial adhesion (Richardson et al., 2006; 2009). In the
event that adhesion is further deregulated, with elimination of the
epithelial seam, (i.e., when a mesenchymal continuity is formed
between palatal shelves and adjacent structures), palatal shelf
elevation is hampered, as observed in Irf6 homozygous mice
(Richardson et al., 2006, 2009). Similar abnormal palate-mandible
or palate-tongue fusion phenotypes have also been reported in
Jagged2mutant, Fgf10mutant and Hand2 hypomorphic mice (Alappat
et al., 2005; Casey et al., 2006; Xiong et al., 2009). In these animal
models, ectopic cell apoptosis is a common cause of disruption in
epithelium integrity. However, since adhesion/fusion always occurs
between two epithelial surfaces, disruption of either surface could
lead to abnormal adhesion/fusion. In Jagged2 mutants, the abnormal
palate-tongue fusion phenotype results from an abnormal tongue
epithelial differentiation, despite normally developed palatal shelves
as assessed at histological, cellular, and molecular levels (Casey et al.,
2006). In Hand2 hypomorphic and Fgf10 mutant mice, the abnormal
palate-mandible fusion has been attributed to ectopic cell apoptosis
within the palatal epithelium (Alappat et al., 2005; Xiong et al., 2009).
As shown in this study, in E13.5 Noggin mutants, ectopic apoptotic
cells were found in the oral side epithelium of the anterior palate and
in themandibular epithelium, but not in the posterior palate (Fig. 5G).
Since the anterior palatal shelves do not make contact with the
mandible, an abnormal palate-mandible fusion does not occur.
However, in the posterior palate at E14.5, we observed ectopic cell
death in the oral side palatal epithelium, but not in the mandibular
epithelium, where abnormal fusion occurred (Fig. 6I). Here, aberrant
apoptosis was initially detected in periderm cells in the abnormal
fusion region prior to making contact with the mandibular epitheli-
um. A similar phenotype was also observed in Hand2 hypomorphic
mice (Xiong et al., 2009). During normal palate development,
periderm cells in the MEE region are removed prior to palatal shelfcontact and subsequent fusion (Fitchett and Hay, 1989), and artiﬁcial
removal of periderm cells causes degradation of the basal layer cells in
the MEE (Cuervo and Covarrubias, 2004). Together, these results
support an essential role for periderm cells in the maintenance of
palatal epithelial integrity.
Differential cellular and gene expression responses to the absence of
Noggin along the A–P axis of developing palate
It has beenwell documented that the developing secondary palatal
shelf is an asymmetric structure along the anterior–posterior axis
(Zhang et al., 2002; Alappat et al., 2005; Yu et al., 2005; He et al.,
2008). The anterior and posterior portions of the palatal shelves differ
not only at the cellular level, but also at the molecular level (reviewed
in Hilliard et al., 2005; Okano et al., 2006; Gritli-Linde, 2007).Noggin is
expressed in the oral side palatal epithelium in both anterior and
posterior palate shelves and Noggin deﬁciency leads to ectopic
activation of BMP/Smad signaling in these structures. Associated
with this enhanced/ectopic BMP/Smad signaling is ectopic cell death
in both anterior and posterior palatal epithelium. However, it is
interesting to note that the timing of the apoptosis occurring varies
along the A–P axis. In the anterior palatal epithelium of Nog−/−
embryo, ectopic cell death was detected as early as E13.5, while in the
posterior palate, ectopic cell death was not detected until E14.5,
suggesting that molecular mechanisms underlying the cell death are
different along the A–P axis. This idea is supported by the fact that
Tgfβ3, which is required for cell death in the MEE during normal
fusion of palate, is ectopically expressed in the posterior palatal
epithelium, but not in the anterior counterpart. These results suggest
that the ectopic Tgfβ3 expression may mediate the cell death in the
posterior palate. The ectopic cell apoptosis found in the anterior
palatal epithelium in Noggin mutant is mediated by a different
mechanism.
In addition, the palatal mesenchymal cells of the anterior and
posterior palate also respond differentially to the loss of Noggin. At the
cellular level, the anterior palatal mesenchyme exhibits a down-
regulated cell proliferation rate; while in the posterior palate, the cell
proliferation rate is not affected (Fig. 5E). In terms of gene expression,
Bmp2 expression was down-regulated in the anterior palatal
mesenchyme, but remained unaltered in the posterior palatal
mesenchyme (Fig. 4). It has been shown previously that Bmp2 acts
downstream of Bmp4 and Shh to stimulate cell proliferation in the
anterior palatal mesenchyme (Zhang et al., 2002). This down-
regulation of Bmp2 expression appears to be responsible for the
reduction in Smad1/5/8 phosphorylation in the anterior palatal
mesenchyme of Nogginmutant, which contributes to the reduced cell
proliferation rate. While Smad1/5/8 phosphorylation was enhanced
in the posterior palatal mesenchyme in the absence of Noggin, the cell
proliferation rate was unaltered, consistent with the previous ﬁnding
that neither BMP2 nor BMP4 regulate cell proliferation in the
posterior palatal mesenchyme (Zhang et al., 2002; Hilliard et al.,
2005). In the posterior palate of Nogginmutant, Bmp2 expression was
not changed in the mesenchyme, but was upregulated in the oral side
epithelium. Although we cannot rule out the possibility that the
expression and/or activity of other BMPs is upregulated in the
posterior palate in the absence of Noggin, the upregulated Bmp2
expression in the oral side epithelium could count for, at least
partially, the ectopic Smad1/5/8 phosphorylation in the oral side
mesenchyme of the Nog−/− posterior palate.
It was shown previously that application of exogenous Noggin
protein to the globular process of the frontonasal mass of developing
chick embryo induces clefts of the primary palate (Ashique et al.,
2002). However, in Nog−/− mice, the absence of Noggin leads to a
complete lack of the primary palate structure (Fig. 1J). These
observations indicate that BMP homeostasis is also essential for
development of the primary palate. There are many lines of evidence
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palate development (Matzuk et al., 1995; Zhang et al., 2002; Dudas
et al., 2004; Liu et al., 2005; Xiong et al., 2009). Interestingly, while
overexpression of Noggin in the palatal mesenchyme leads to cleft
palate formation (Xiong et al., 2009), Noggin overexpression in the
palatal epithelium does not cause a cleft palate defect (Fig. 7E, and
Supplemental Fig. 1F), despite of the fact that K14Cre;pMesNog mice
show an arrest of tooth development at the lamina/early bud stage
(data not shown). This is likely due to different amounts of transgenic
Noggin produced in the palatal mesenchyme and the palatal
epithelium. The different responses of the developing palate and
tooth to Noggin overexpression in the epithelium could be attributed
to differential sensitivity to altered BMP signaling.
Bmp4 is unable to compensate for the reduction of Bmp2 expression in
the anterior palate in vivo
While it remains to be determined how Bmp2 expression is
differentially regulated in the developing palate along the A–P axis in
the Noggin mutant, it is interesting to note that Bmp4 expression is
unaltered. BMPs, including BMP2, BMP4 and BMP7, have been shown
to function as mitogens in developing craniofacial structures (Barlow
and Francis-West, 1997;Wang et al., 1999; Ashique et al., 2002; Zhang
et al., 2002). Bmp2 and Bmp4 are expressed in a partially overlapping
pattern in the anterior palate mesenchyme. Although exogenously
applied BMP2 or BMP4 can equally induce cell proliferation in the
anterior palatal mesenchyme in vitro (Zhang et al., 2002; Hilliard et
al., 2005), the unaltered Bmp4 expression in the Nog−/− palate
suggests that Bmp4 fails to compensate for the reduction of Bmp2
expression, in terms of activating BMP/Smad signaling and regulating
cell proliferation, in the anterior palatal mesenchyme in vivo. Similar
results have also been previously demonstrated in an in vitro study in
which blocking Shh signaling did not affect Bmp4 expression but
eliminated Bmp2 expression and subsequently inhibited cell prolifer-
ation in the anterior palatal mesenchyme (Zhang et al., 2002). Thus,
Bmp4 appears to maintain Msx1 expression in the mesenchyme and
Shh expression in theMEE, while Bmp2 is primarily responsible for the
regulation of cell proliferation within the anterior palatal mesen-
chyme. This hypothesis is supported by the fact that expression
pattern of pSmad1/5/8 in the developing palate is almost identical to
that of Bmp2 in both the anterior and posterior portion (Figs. 3 and 4).
In addition, we also observed a signiﬁcantly reduced Shox2 expression
in the anterior palatal mesenchyme of Noggin mutants. We have also
demonstrated previously that BMP activities are not sufﬁcient to
induce ectopic Shox2 expression, but are necessary for Shox2
expression in the anterior palatal mesenchyme (Yu et al., 2005).
Given the fact that Bmp4 expression remains unaltered in the Nog−/−
anterior palate, it cannot maintain Shox2 expression at the wild type
level. BMP4 and BMP2 indeed have differential potency in activating
BMP/Smad signaling (Upton et al., 2008), and BMP2/BMP4 hetero-
dimers are more potent than homodimers of any of the proteins in
activating BMP/Smad signaling. This functional difference is likely due
to different binding afﬁnities between speciﬁc BMP ligands and
receptors, or availability of BMP receptors in speciﬁc cell context.
Currently, three type I receptors (BMPR-IA, BMPR-IB, and ActRIa) and
three type II receptors (BMPR-II; ActRIIA, and ActRIIB) have been
identiﬁed to bind to BMP ligands with different afﬁnities (Sieber et al.,
2009). Expression of BMP receptors and their functions in palate
development warrant future investigation.
BMPR-IA likely mediates overactive BMP signaling in disruption of
palatal epithelial integrity
During development and disease, BMP signaling is involved in the
regulation of multiple cellular processes, including proliferation and
apoptosis. In the palatal epithelium of Nogginmutants, in which BMPsignaling is overactive, we observed the simultaneous occurrence of
elevated level of cell proliferation and excess apoptotic cells. This
simultaneous elevation of cell proliferation rate and apoptosis was
also observed in the palatal mesenchyme in mice bearing inactivation
of Alk5 in neural crest cells and their derivatives (Dudas et al., 2006).
In the posterior palate of Noggin mutant, the excess cell apoptosis in
the palatal epithelium resulted in abnormal palate-mandible fusion.
This phenotype was recapitulated by ectopic expression of a
constitutively active form of BMPR-IA in the palatal epithelium. In
contrast, ectopic expression of a constitutively active form of BMPR-IB
did not produce any obvious palate defect. Since Bmp2 expression and
Smad1/5/8 phosphorylation were elevated in the region where
excess cell death and abnormal fusion occurred, it appears that
overexpressed BMP2 acts through BMPR-IA and Smad-dependent
pathway in this context, leading to the disruption of palatal epithelial
integrity. This view is supported by the observations of high binding
afﬁnity of BMP2 to BMPR-IA (Knaus and Sebald, 2001), and Bmpr-IA
but not Bmpr-IB is strongly expressed in the palatal epithelium during
palatogenesis (Li, L. and Chen, Y.P., unpublished results).
In conclusion, our studies show an absolute requirement for
Noggin in normal palate development. The absence of Noggin alters
the levels of BMP signaling, causing aberrant cell proliferation and cell
death in the developing palate. Repression of BMP activities by Noggin
in the palatal epithelium is essential for the maintenance of
epithelium integrity. Our results highlight the importance of ﬁne-
tuned BMP signaling in palate formation.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.08.014.
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